Abstract

XIV. The rationale for combining targeted and biological anti‐lymphoma drugs

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Current Status of Targeted Therapies for Mantle Cell Lymphoma
Julie E Chang ... Brad S Kahl
Drugs | VOL. 71
Julie E Chang, et. al.Julie E Chang ... Brad S Kahl
01 Dec 2011
Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines
Sakura Sakajiri ... H Phillip Koeffler
Experimental hematology | VOL. 33
Sakura Sakajiri, et. al.Sakura Sakajiri ... H Phillip Koeffler
01 Jan 2004
Historical review of lymphomas.
Alan C. Aisenberg
British journal of haematology | VOL. 109
Alan C. AisenbergAlan C. Aisenberg
01 Jun 2000
Abstract A124: Co-treatment with BRD4 antagonist and histone deacetylase inhibitor is synergistically lethal against Mantle Cell Lymphoma (MCL) cells.
Bhavin Shah ... Kapil N Bhalla
Molecular Cancer Therapeutics | VOL. 12
Bhavin Shah, et. al.Bhavin Shah ... Kapil N Bhalla
01 Nov 2013
View more papers

More From: Hematological oncology

Paper Title
Journal
Date
Author
Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy.
Danai Dima ... Jack Khouri
Hematological oncology | VOL. 42
Danai Dima, et. al.Danai Dima ... Jack Khouri
01 Jul 2024
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials.
Enrica Antonia Martino ... Concetta Conticello
Hematological oncology | VOL. 42
Enrica Antonia Martino, et. al.Enrica Antonia Martino ... Concetta Conticello
01 Jul 2024
Metabolic pathway-based subtyping reveals distinct microenvironmental states associated with diffuse large B-cell lymphoma outcomes.
Xiaohui Wang ... Hengqi Liu
Hematological oncology | VOL. 42
Xiaohui Wang, et. al.Xiaohui Wang ... Hengqi Liu
01 Jul 2024
-
-
Hematological oncology | VOL. 42
--
01 Jul 2024
View more papers